Mark J. Roschewski, M.D.

Mark J. Roschewski, M.D.
Staff Clinician

Team Member of:

Dr. Roschewski is a staff clinician within the lymphoma research program at the NCI that focuses on the management of aggressive lymphomas such as diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma, and Burkitt lymphoma. Recent studies from NCI show that dose-adjusted EPOCH-R therapy is highly effective for subtypes of DLBCL such as primary mediastinal B-cell lymphoma and GCB-subtype of DLBCL. The NCI group also focuses on developing novel therapies for molecular subtypes of DLBCL with a poor prognosis such as mediastinal gray zone lymphomas, ABC DLBCL and MYC+ DLBCL. Dr. Roschewski’s clinical research also involves non-invasive methods of monitoring patients with myeloma and lymphoma after therapy with minimal residual disease assays.

Areas of Expertise
minimal residual disease (MRD) in lymphoid malignancies, aggressive lymphomas, mantle cell lymphoma and indolent lymphomas, EBV-associated lymphomas, smoldering myeloma and myeloma precursor diseases

Contact Info

Mark J. Roschewski, M.D.
Center for Cancer Research
National Cancer Institute
Building 10, Room 3-2340
Bethesda, MD 20892
Ph: 301-451-9021

Selected Publications

  1. Roschewski M, Staudt LM, Wilson WH.
    Nat Rev Clin Oncol. 11: 41996, 2014. [ Journal Article ]
  2. Roschewski M, Dunleavy K, Wilson WH.
    Leuk. Lymphoma. [Epub ahead of print], 2014. [ Journal Article ]
  3. Roschewski M, Korde N, Wu SP, Landgren O.
    Blood. 122: 486-90, 2013. [ Journal Article ]
  4. Roschewski M, Stetler-Stevenson M, Yuan C, Mailankody S, Korde N, Landgren O.
    J. Clin. Oncol.. 32: 475-6, 2014. [ Journal Article ]
  5. Roschewski M, Wilson WH.
    Best Pract Res Clin Haematol. 25: 75-89, 2012. [ Journal Article ]

Dr. Mark Roschewski received his B.A. from the University of Notre Dame in 1997 and his M.D. from the University of Nebraska Medical Center in Omaha in 2001. He completed internal medicine residency training while serving in the U.S. Army and completed his hematology-oncology fellowship in 2009 at Walter Reed Army Medical Center (WRAMC) in Washington, DC. He served as the Director of Hematologic Diseases at WRAMC for 3 years before joining the NIH as a Commissioned Corps officer in the United States Public Health Service in 2013. Dr. Roschewski's current role is as a staff clinician in the Lymphoid Malignancies Section of the Metabolism Branch with a clinical research focus on non-Hodgkin's lymphoma, Hodgkin lymphoma, and multiple myeloma.